"Designing Growth Strategies is in our DNA"

Recombinant Proteins Market Size, Share & Industry Analysis, By Type (Hormones, Growth Factors, Antibody, Enzyme, Others), By Application (Therapeutic, Research), By End User (Biopharmaceutical Companies, Academic & research Institutes, Others) and Regional Forecast 2021-2028

Region : Global | Report ID: FBI103492 | Status : Ongoing

 

KEY MARKET INSIGHTS

For the drug development & discovery process, recombinant proteins are being widely used owing to its advantage of protein expression in useful protein products. Dueto the increased prevalence of COVID-19 pandemic, researchers are using the recombinant protein products in the detection of COVID-19 and related virus. This has increased the potentiality of the market. Moreover, products such as recombinant enzymes, growth factors, cell check points are utilized in the research activities pertaining to cancer types. The above mentioned factors are responsible for the growth of the market during the forecast period.


The major factor driving the global recombinant proteins market is growing demand for recombinant proteins products for the use in advanced research, drug development & discovery etc. Additionally, rising prevalence of chronic disease have ultimately led to the increased adoption of recombinant proteins to launch therapeutically effective drugs in the market. These factors are responsible for the rising market trend during the projected period.


On the flip side, biopharmaceutical companies are undergoing challenges in receiving regulatory approval. This is likely to hinder the market growth.


Key Market Driver -

Increased R&D Expenditure for the Launch of Novel Therapeutic Products

Key Market Restraint -

Challenges in Regulatory Approval


Market Segmentation:


By type, the market is segmented into hormones, growth factor, antibody, enzyme, and others. Based on application, the market is segmented into therapeutic and research. Based on end user, the global recombinant proteins market is classified as biopharmaceutical companies, academic & research institutes, and others.


From a geographical standpoint, the market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.


Key Players Covered:


The major companies in the global recombinant proteins market report includes Sigma Aldrich Company Ltd., Novoprotein Scientific, Thermo Fisher Scientific, Merck KGaA, Abcam PLC, Lonza, GenScript Biotech Corporation, ProSpec Tany TechnoGene, Ltd., and others.


Key Insights



  • New Product Launch

  • Pipeline Analysis

  • COVID-19 Pandemic Impact on the Global Market

  • Key Industry Developments – Mergers, Acquisitions, and Partnerships


Regional Analysis:


The global recombinant proteins market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America followed by Europe dominated the global recombinant proteins market in 2019, owing to the rise in R&D of the pharmaceutical & biotechnology industries. Additionally, growing consolidation between small and medium sized companies operating in recombinant proteins development is likely to surge the market growth in Asia Pacific. Moreover, increased sales of products in the use of R&D experiments is fostering the market growth in the Asia Pacific countries. Latin America and Middle East & Africa are projected to register a comparatively lower CAGR by the end of the forecast period.


To gain extensive insights into the market, Request for Customization


Segmentation


























 ATTRIBUTE


  DETAILS

By Type




  • Hormones

  • Growth Factors

  • Antibody

  • Enzyme

  • Others



By Application




  • Therapeutic

  • Research



By End User




  • Biopharmaceutical Companies

  • Academic & research Institutes

  • Others



By Geography




  • North America (USA, Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and the Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and the Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, the Rest of Latin America)

  • Middle East & Africa (South Africa, GCC and the Rest of Middle East & Africa)



Particle Therapy Industry Developments



  • In June 2020, Lonza launched a new media GSv9 to support the recombinant proteins production using Lonza’s GS Gene Expression System.

  • In March 2020, AMS Biotechnology launched recombinant proteins and antibodies for the detection of COVID-19 virus. The company has wide range of products such as assays, recombinant proteins, and cell lines particularly for drug development.


Recombinant Proteins Market Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2020
  • 2017-2019

    CHOOSE LICENSE TYPE

  • $4850
    $6850
    $8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Styker
Johnson
Pfizer
3M
Ansell

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X